Cardiac Allograft Vasculopathy and Secondary Outcomes of Hepatitis C Positive Donor Hearts at One-Year Post-Transplantation

The continued shortage of donor organs, together with a sustained increase in the number of potential donors with hepatitis C virus (HCV) infection (related to the ongoing opioid epidemic) and the advent of direct acting antiviral agents(DAA), has led to increased utilization of HCV-positive donors for heart transplantation(HT) (1). Furthermore, multiple recent studies have shown that 1-year HT-survival using HCV-positive donors in the current era of DAAs is similar to HT-survival using non-HCV donors (1,2).

Source: The Journal of Heart and Lung Transplantation - June 29, 2020 Category: Transplant Surgery Authors: Shivank Madan, Snehal R. Patel, Ulrich P. Jorde Tags: Research correspondence Source Type: research